Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ZONAGEN INC | 2,709,036 | reported | 15 Dec 2009 | tx 26+2,199,180−688,157 |
| Inhibrx Biosciences, Inc. | 705,548 | reported | 16 Sept 2024 | tx 15+1,225,413 |
| Inhibrx, Inc. | 0 | reported | 30 May 2024 | tx 23+745,000−3,868,714 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Sept 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 13,037 | 17.13 USD | |
| 12 Sept 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 26,963 | 15.05 USD | |
| 10 Sept 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 8,500 | 15.19 USD | |
| 09 Sept 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 9,500 | 15.21 USD | |
| 06 Sept 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 26,000 | 15.29 USD | |
| 03 Sept 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 4,712 | 16.31 USD | |
| 03 Sept 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 15,288 | 15.66 USD | |
| 30 Aug 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 10,000 | 14.02 USD | |
| 29 Aug 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 10,000 | 14.03 USD | |
| 20 Aug 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 27,055 | 12.97 USD | first after silence |
| 21 Aug 2024 | PURCHASE | Inhibrx Biosciences, Inc. | 12,945 | 12.93 USD | |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 500,000 | 30.00 USD | |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 59,462 | 30.00 USD | |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 2,486,192 | 30.00 USD | |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 145,000 | — | deriv |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 100,000 | — | deriv |
| 29 May 2024 | GRANT_AWARD | Inhibrx Biosciences, Inc. | 14,865 | — | |
| 29 May 2024 | GRANT_AWARD | Inhibrx Biosciences, Inc. | 125,000 | — | |
| 29 May 2024 | GRANT_AWARD | Inhibrx Biosciences, Inc. | 621,548 | — | |
| 30 May 2024 | GRANT_AWARD | Inhibrx Biosciences, Inc. | 300,000 | 0.00 USD | deriv |
| 28 Feb 2023 | SALE | Inhibrx, Inc. | 60 | 25.02 USD | |
| 03 Jan 2023 | GRANT_AWARD | Inhibrx, Inc. | 100,000 | 0.00 USD | deriv |
| 19 Dec 2022 | SALE | Inhibrx, Inc. | 754 | 26.29 USD | |
| 19 Dec 2022 | SALE | Inhibrx, Inc. | 25,246 | 25.53 USD | |
| 17 Nov 2022 | SALE | Inhibrx, Inc. | 6,959 | 25.36 USD |
1 purchase reported after at least 12 months of silence — most recent on 20 Aug 2024.